Pharma Aids Limited (DSE:PHARMAID)
590.00
-3.00 (-0.51%)
At close: Feb 10, 2026
Pharma Aids Market Cap
Pharma Aids has a market cap or net worth of 1.84 billion as of February 12, 2026. Its market cap has increased by 6.54% in one year.
Market Cap
1.84B
Enterprise Value
1.82B
Revenue
453.49M
Ranking
n/a
PE Ratio
27.31
Stock Price
590.00
Market Cap Chart
Since August 5, 2004, Pharma Aids's market cap has increased from 8.88M to 1.84B, an increase of 20,632.07%. That is a compound annual growth rate of 28.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.84B | 21.88% |
| Dec 30, 2025 | 1.51B | -15.56% |
| Dec 30, 2024 | 1.79B | -27.49% |
| Dec 28, 2023 | 2.47B | - |
| Dec 29, 2022 | 2.47B | 31.70% |
| Dec 30, 2021 | 1.87B | 26.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 8.37B |
| Orion Pharma | 6.95B |
| Navana Pharmaceuticals | 6.50B |
| Techno Drugs | 4.18B |
| Ambee Pharmaceuticals | 1.88B |
| Libra Infusions | 1.60B |
| Silco Pharmaceuticals | 1.47B |
| Indo-Bangla Pharmaceuticals | 1.44B |